A R T I C L E I N F O
Article type:
Original article
Article history:
Received: May 14, 2016
Accepted: Jan 12, 2017
Keywords:
Cataract
Congenital
Connexine 50 gene
GJA8
Mutation
A B S T R A C T
Objective(s): Childhood cataract is a genetically heterogeneous eye disorder that results in visual impairment. The aim of this study was to identify the genetic mutations of connexin 50 gene among Iranian families suffered from autosomal dominant congenital cataracts (ADCC).
Materials and Methods: Families, having at least two members with bilateral familial congenital cataract, were selected for the study. Probands were evaluated by detailed ophthalmologist's examination, and the pedigree analysis was performed. PCR amplifications were performed corresponding to coding region and intron-exon boundaries of GJA8, a candidate gene responsible for ADCC. PCR products were subjected to bidirectional sequencing, and the co-segregation of identified mutations was examined and finally, the impact of identified mutations on biological functions of GJA8 was predicted by in silico examination.
Results: Three different genetic alterations, including c.130G>A (p.V44M), c.301G>T (p.R101L) and c.134G>T (p.W45L) in GJA8 gene were detected among three probands. Two identified mutations, W45L and V44M have been already reported, while the R101L is a novel mutation and its cosegregation was examined. This mutation was exclusively detected in the ADCC and could not be found among the healthy control group. The result of bioinformatic studies of R101L mutation predicted that this amino acid substitution within GJA8 could be a disease-afflicting mutation due to its potential effect on the protein structure and biological function.
Conclusion: Our results suggest that mutations of lens connexin genes such as GJA8 gene could be one of the major mechanisms of cataract development, at least in a significant proportion of Iranian patients with ADCC.
Introduction
Childhood cataract is one of the most frequent causes of treatable childhood blindness. This disease is a genetically heterogeneous eye disorder, which affects the central nucleus of the eye and frequently results in visual impairment or even blindness in children. The prevalence of congenital cataract is estimated between 1 and 15 in 10,000 newborns (1). Congenital cataract occurs in all genders, races and ethnicities. It has been reported that the rate of congenital/infantile cataract in males was 10% higher than females (2-4).
To date, surgery has been the first line of treatment for congenital cataract, but it has many complications such as strabismus, nystagmus, amblyopia, posterior capsular opacity, and glaucoma.
So, despite dramatic improvements in the treatment of congenital cataracts, still a large proportion (75%) of childhood blindness in developing countries is due to congenital cataract (2-6).
Although the aforementioned disease can be either bilateral or unilateral, and also with or without genetic basis, it has been shown that the unilateral cataract is rarely inherited, whereas approximately 50% of bilateral cases have a genetic background. This trait can be transmitted in different patterns such as autosomal dominant, autosomal recessive and X-linked; however, the autosomal dominant pattern seems to be the most common inheritance pattern (1, 7, 8).
Identification of the genetic variations underlying hereditary cataract and subsequent functional studies will improve our insight into normal and abnormal lens development and the mechanisms of cataract pathogenesis. Although identification of genetic variations in congenital cataract has not yet led to establish a better and newer treatment, it may be possible to cure congenital cataracts before birth or in early childhood with advances in genetic science.
So far, several chromosomal regions are suggested to be involved in the molecular etiology of the disease. In addition, several genes such as crystallin genes (CRYAA, CRYAB, CRYBB1, CRYBB2, CRYBA1/A3, CRYGA, CRYGB, CRYGC, CRYGD, and CRYGS), GJA3, GJA8, MP and AQP0) have been reported to be associated with the inherited cataract (1, 7-12). Although more than 90% of soluble lens proteins consist of crystallin proteins, connexin proteins play an important role in maintenance of lens structure and transparency by controlling water and ion balance in the lens. The mutations identified in the connexin genes that encode these corresponding proteins have been associated with inheritance of cataracts in human (9-12).
In the present study, we conducted a mutation screening of the entire coding sequences of GJA8 gene; the gene which encodes connexin proteins, among ten Iranian families with ADCC.
Materials and Methods
Ocular examination
This study was approved by the Institutional Review Board Committees (IRB) at Tehran University of Medical Sciences (TUMS, Iran). A written informed consent was obtained from parents or guardians before mutation analysis. In this study, 20 patients from 10 unrelated Iranian families with ADCC were diagnosed and enrolled based on the following criteria: (1) bilateral congenital cataracts that had been approved by detailed ophthalmologist's examination; (2) no other ocular or systemic disease; (3) no other congenital and syndrome related malformation; (4) no history of any teratogenic drug use during pregnancy; (5) compatible family pedigree with an autosomal dominant pattern of the disease. The exclusion criteria were the various diseases, infections, or trauma that mimics inherited cataracts as well as individuals requiring sedation for study procedures.
Molecular genetic studies
Genomic DNA was isolated from five milliliters whole blood using a QIAamp DNA mini kit (Qiagen, Hilden, Germany). The PCR amplification was typically carried out using specific primer pairs of coding regions (http://simgene.com/Primer3) and exon-intron boundaries of GJA8 gene (Table 1), 0.2U Taq DNA polymerase (Roche, Mannheim, Germany), 10 pmole of each primer, 200 gM of each dNTPs, 0.67 gl of 50 mM MgCl2, 60 ng DNA and 2.5 gl of PCR buffer in 25 gl of PCR reactions. The PCR conditions included an initial denaturation step for 3 min at 95 °C, 30 sec at 95 °C, 45 sec at 64 °C with a 1 °C decrease every second cycle down to 55 °C, then 55 °C for 14 cycles, 1 min at 72 °C for extension, and finally 10 min at 72 °C (13-15). PCR products were separated on 2% agarose gels and visualized with ethidium bromide, as described previously (15-18).
Subsequently, to determine any mutation the PCR product was subjected to direct sequencing (Gene Fanavaran, Iran). Sequence data searches were performed in non-redundant nucleic and protein databases BLAST (http://www.ncbi.nlm.nih.gov/BLAST).
In silico study
In order to investigate whether the identified mutation could affect the biological function of the altered protein, we analyzed the mutated form of protein using Polyphen2 program (http://genetics.bwh.harvard.edu/pph2/).
Results
According to studied medical records, interviewing the patients, and medical examinations, probands from ten families with ADCC were enrolled in this study. All probands and their families were clinically examined by an ophthalmologist to identify ADCC affected individuals. Genetic analysis of these probands revealed three missense mutations including c.130G>A (p.V44M), c.301G>T (p.R101L) and c.134G>T (p.W45L) in GJA8 gene.
In family 1, the proband was a 3-year-old girl from a family with 12 ADCC affected individuals. She was afflicted with posterior polar cataract and reduced visual acuity (VA). The affected patient underwent slit lamp assessment. Molecular genetic studies revealed a novel mutation c.301G>T (p.R101L) in the GJA8 gene. The aforementioned mutation also was detected in GJA8 gene of her mother who suffered from ADCC (Figure 1). This mutation was not observed in any of the unaffected family members or in the 100 healthy control individuals.
In family 2, the proband was a 4-year-old girl from a family with 4 affected individuals with ADCC. Ocular examination using slit- lamp confirmed posterior polar cataract. Through bidirectional sequencing of entire coding regions and intron-exon boundaries of the GJA8 gene, a missense mutation, c.130 G>A (p.V44M), was identified. In the affected members of family 2, the known mutation, c.130 G>A (p.V44M), was detected in the GJA8 gene (Figure 2).
In family 3, the proband was a 4-year old boy from a family with 11 ADCC affected individuals. Mutation analysis of GJA8 using bidirectional sequencing as described above revealed a missense mutation, c.134 G>T (p.W45L). This mutation was also detected in the GJA8 gene of other affected family members (Figure 3).
In silico study
In order to predict the potential biological effect of the novel missense mutation (R101L) within coding region of GJA8 gene, we utilized the Polyphen 2 program. The mutation analysis predicted this alteration as"probably damaging".
Discussion
So far, along with the development of molecular genetics, various loci and more than 20 genes such as CRYAA, CRYAB, CRYBA1/A3, and GJA8 have been reported to be associated with congenital cataracts (7, 9-12). In this study, we conducted mutation detection within GJA8 gene among ten Iranian families with ADCC. Three missense mutations, including c.130G>A (p.V44M), c.301G>T (p.R101L) and c.134G>T (p.W45L) in the coding region of GJA8 (Cx50) gene were detected in the patients with ADCC.
Gap junction proteins, are a unique family of transmembrane proteins that form specific channels between cells and are encoded by a gene family with at least 14 members. These proteins connect the cytoplasm of neighboring cells and play an important role in intercellular communication in the lens. The GJA8 gene encodes 433 amino acid residues of gap junction protein alpha 8 or connexin 50. The encoded protein contains four transmembrane domains that are joined by two extracellular and one cytoplasmic loop and flanked by cytoplasmic N- and C-termini. This protein creates gap junction channels by forming hexamers, or hemi-channels, that can dock between adjacent cells. The normal function of These channels have been shown to be involved in the trafficking of ions and small molecular metabolites (19-24).
Studies have reported that GJA8 mutations are responsible for a significant proportion of ADCC (1, 7, 25, 26). Up to now, more than 20 mutations in GJA8 gene have been reported in hereditary congenital cataract (1, 7, 8, 19, 23, 25-27). Even though our results are the first report that demonstrated the genetic alterations of GJA8 gene in Iranian population, various studies reported the association of GJA8 mutations with ADCC in different ethnic groups (25-27).
Two out of three identified mutations, c.130G>A (p.V44M) and c.134G>T (p.W45L) (V44M and W45L), through the present work, are located in the extracellular loop 1 near the TM1/E1 border. It has been well documented that this part of GJA8 gene is supposed to be a hot-spot sequence. In line with our suggestion, several studies reported a high incidence rate of mutation in this region among congenital cataract (18-20, 22-28). Additionally, different studies have shown that mutations in this region impair the normal functions of Cx50 and are introduced as disease-causing mutation in ADCC (29, 30).
Moreover, our in silico study of c.130G>A (p.V44M) and c.134G>T (p.W45L) mutations, which are located on the first exon of GJA8 gene, predicted that these mutations are"probably damaging" to the structure and function of the protein (with a specificity of 0.99 and 1.00, respectively). Then, this is quite understandable that these mutations likely lead to the disruption of the gap junction formation and altered protein trafficking or channel assembly of heteromeric connexins consisting of GJA8 mutant and wild-type subunits.
The third identified genetic variation c.301G>T (p.R101L) seems to be a novel mutation. Bioinformatic studies using Polyphen program suggested that the R101Las is "probably damaging" with a score of 0.997 and specificity of 0.98. This result is justified by the different characteristics of arginine and leucine. Arginine has a basic polarity and positively charged R group, and hydropathy index of -4.5, which is totally different from leucine with a non-polar, neutral R group, and hydropathy index of +3.8. Therefore, this base substitution might completely change the 3D structure, characteristics, and normal function of the resulting protein. Further studies are required to reveal the possible implication of this genetic alteration with ADCC.
Conclusion
We identified a novel heterozygous c301G>T (p.R101L) genetic variation and two known mutations in GJA8 in the three Iranian families with ADCC. Our data also showed that the mutation in GJA8 gene accounts for ~30% of ADCC in Iranian population. The in silico and experimental studies suggested that these genetic alterations might be vital in hemichannel formation. However, further investigations are essential to define the exact molecular mechanisms, which are implicated by these mutations in the abnormal function as well as their pathogenic effects on the development of ADCC.
Acknowledgment
This work was supported by Tehran University of Medical Sciences (TUMS). We also thank staff of the genetic department from Farabi Hospital for key contributions.
* Please cite this article as:
Mohebi M, Chenari S, Akbari A, Ghassemi F, Zarei-Ghanavati M, Fakhraie Gh, Babaie N, Heidari M. Mutation analysis of connexin 50 gene among Iranian families with autosomal dominant cataracts. Iran J Basic Med Sci 2017; 20:288-293; 10.22038/IJBMS.2017.8358
References
1. Yi J, Yun J, Li ZK, Xu CT, Pan BR. Epidemiology and molecular genetics of congenital cataracts. Int J Ophthalmol, 2011; 4:422-432.
2. Mohebi M, Akbari A, Babaei N, Sadeghi A, Heidari M. Identification of a De Novo 3bp Deletion in CRYBA1/A3 Gene in Autosomal Dominant Congenital Cataract. Acta Med Iran 2016;54(12):778-783.
3. Rong X, Ji Y, Fang Y, Jiang Y, Lu Y. Long-Term Visual Outcomes of Secondary Intraocular Lens Implantation in Children with Congenital Cataracts. PLoS One 2015; 10:e0134864.
4. Sukhija J, Kaur S, Ram J. Outcome of a new acrylic intraocular lens implantation in pediatric cataract. J Pediatr Ophthalmol Strabismus 2015; 52:371-376.
5. Umar MM, Abubakar A, Achi I, Alhassan MB, Hassan A. Pediatric cataract surgery in National Eye Centre Kaduna, Nigeria: outcome and challenges. Middle East Afr J Ophthalmol 2015; 22:92-96.
6. Wang M, Xiao W. Congenital cataract: progress in surgical treatment and postoperative recovery of visual function. Eye Sci 2015; 30:38-47.
7. Hejtmancik JF, Smaoui N. Molecular genetics of cataract. Dev Ophthalmol 2003; 37:67-82.
8. Huang B, He W. Molecular characteristics of inherited congenital cataracts. Eur J Med Genet 2010; 53:347-57.
9. Deng H, Yuan L. Molecular genetics of congenital nuclear cataract. Eur J Med Genet 2014; 57:113-122.
10. Garnai SJ, Huyghe JR, Reed DM, Scott KM, Liebmann JM, Boehnke M, et al. Congenital cataracts: de novo gene conversion event in CRYBB2. Mol Vis 2014; 20:1579-1593.
11. He W, Li S. Congenital cataracts: gene mapping. Hum Genet 2000; 106:1-13.
12. Reddy MA, Francis PJ, Berry V, Bhattacharya SS, Moore AT. Molecular genetic basis of inherited cataract and associated phenotypes. Surv Ophthalmol 2004; 49:300-315.
13. Mobini G, Ghahremani M, Amanpour S, Dehpour A, Akbari A, Hoseiniharouni S, et al. Transforming growth factor beta-induced factor 2-linked X (TGIF2LX) regulates two morphogenesis genes, Nir1 and Nir2 in human colorectal. Acta Med Iran 2016; 54:302-307.
14. Akbari A, Ghahremani MH, Mobini GR, Abastabar M, Akhtari J, Bolhassani M, et al. Down-regulation of miR-135b in colon adenocarcinoma induced by a TGF-ß receptor I kinase inhibitor (SD-208). Iran J Basic Med Sci 2015; 18:856-861.
15. Yazdi MK, Akbari A, Soltan Dallal MM. Multiplex polymerase chain reaction (PCR) assay for simultaneous detection of shiga-like toxin (stx1 and stx2), intimin (eae) and invasive plasmid antigen H (ipaH) genes in diarrheagenic Escherichia coli. Afr J Biotechnol 2011; 109:1522-1526.
16. Akbari A, Mobini GR, Maghsoudi R, Akhtari J, Faghihloo E, Farahnejad Z. Modulation of transforming growth factor-ß signaling transducers in colon adenocarcinoma cells induced by staphylococcal enterotoxin B. Mol Med Rep 2016; 13:909-991.
17. Akbari A, Farahnejad Z, Akhtari J, Abastabar M, Mobini GR, Mehbod AS. Staphylococcus aureus Enterotoxin B Down-Regulates the Expression of Transforming Growth Factor-Beta (TGF-ß) Signaling Transducers in Human Glioblastoma. Jundishapur J Microbiol 2016; 9:e27297.
18. Akbari A, Amanpour S, Muhammadnejad S, Ghahremani MH, Gaffari SH, Dehpour AR, et al. Evaluation of antitumor activity of a TGF-beta receptor I inhibitor (SD-208) on human colon adenocarcinoma. Daru J Pharm Sci. 2014;22:47-54.
19. Beyer EC, Berthoud VM. Connexin hemichannels in the lens. Front Physiol 2014; 5:20.
20. Chen C, Sun Q, Gu M, Liu K, Sun Y, Xu X. A novel Cx50 (GJA8) p.H277Y mutation associated with autosomal dominant congenital cataract identified with targeted next-generation sequencing. Graefes Arch Clin Exp Ophthalmol 2015; 253:915-924.
21. Jiang JX. Gap junctions or hemichannel-dependent and independent roles of connexins in cataractogenesis and lens development. Curr Mol Med 2010; 10:851-863.
22. Li J, Wang Q, Fu Q, Zhu Y, Zhai Y, Yu Y, Zhang K, Yao K. A novel connexin 50 gene (gap junction protein, alpha 8) mutation associated with congenital nuclear and zonular pulverulent cataract. Mol Vis 2013; 19:767-774.
23. Minogue PJ, Tong JJ, Arora A, Russell-Eggitt I, Hunt DM, Moore AT, et al. A mutant connexin50 with enhanced hemichannel function leads to cell death. Invest Ophthalmol Vis Sci 2009; 50:5837-5845.
24. Pfenniger A, Wohlwend A, Kwak BR. Mutations in connexin genes and disease. Eur J Clin Invest 2011; 41:103-116.
25. Rubinos C, Villone K, Mhaske PV, White TW, Srinivas M. Functional effects of Cx50 mutations associated with congenital cataracts. Am J Physiol Cell Physiol 2014; 306:C212-220.
26. Zhu Y, Yu H, Wang W, Gong X, Yao K. Correction: A Novel GJA8 Mutation (p.V44A) Causing Autosomal Dominant Congenital Cataract. PLoS One 2015; 10:e0125949.
27. Zhu Y, Yu H, Wang W, Gong X, Yao K. A novel GJA8 mutation (p.V44A) causing autosomal dominant congenital cataract. PLoS One 2014; 9:e115406.
28. Wang L, Luo Y, Wen W, Zhang S, Lu Y. Another evidence for a D47N mutation in GJA8 associated with autosomal dominant congenital cataract. Mol Vis 2011; 17:2380-2385.
29. Mackay DS, Bennett TM, Culican SM, Shiels A. Exome sequencing identifies novel and recurrent mutations in GJA8 and CRYGD associated with inherited cataract. Hum Genomics 2014; 8:19.
30. Ren Q, Riquelme MA, Xu J, Yan X, Nicholson BJ, Gu S, et al. Cataract-causing mutation of human connexin 46 impairs gap junction, but increases hemichannel function and cell death. PLoS One 2013; 8:e74732.
31. Sarkar D, Ray K, Sengupta M. Structure-function correlation analysis of connexin50 missense mutations causing congenital cataract: electrostatic potential alteration could determine intracellular trafficking fate of mutants. Biomed Res Int 2014; 2014:673895.
Masoumeh Mohebi 1, Saeed Chenari 1, Abolfazl Akbari 2, Fariba Ghassemi 1, Mehran Zarei-Ghanavati 1 Ghasem Fakhraie 1 Nahid Babaie 3, Mansour Heidari 3, 4, 5*
1 Farabi Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran
3 Department of Molecular Biology and Genetics, Islamic Azad University, Bushehr Branch, Bushehr, Iran
4 Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
5 Experimental Medicine Research Center, T ehran University of Medical Sciences, T ehran, Iran
*Corresponding author:Mansour Heidari. Department of Molecular Biology and Genetics, Islamic Azad University, Bushehr Branch, Bushehr, Iran. email: [email protected]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright Mashhad University of Medical Sciences Mar 2017